Results 91 to 100 of about 12,493 (244)

Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan [PDF]

, 2022
Masataka Kuwana, Naoko Wakasugi, Toshinori Furuya, Satoshi Uno, Takafumi Suda   +4 more
openalex   +1 more source

The Challenges of Vascular Implants: Regulatory Strategies and Biological Responses

Small Science, Volume 5, Issue 12, December 2025.
Implantable vascular devices are revolutionizing the management of cardiovascular diseases, such as heart failure, by enabling real‐time monitoring and individualized therapy. However, their potential is challenged by regulatory constraints and biological barriers, as device implantation into a vessel can trigger inflammation, thrombosis, and long‐term
Serena Babboni, Rosa Sicari, Lara Russo, Virgilio Mattoli, Giuseppina Basta, Serena Del Turco   +5 more
wiley   +1 more source

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]

, 2013
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
A Bate, A Clarke, A Pariente, AK Chung, Ariola Koci, B Darpo, BJ Drew, C Meyer-Massetti, DM Roden, DW Hough, E Poluzzi, E Poluzzi, E Poluzzi, E Raschi, E Raschi, Edoardo Spina, Elijah R. Behr, Elisabetta Poluzzi, Emanuel Raschi, EP Puijenbroek van, ER Behr, F Ponti De, F Ponti De, F Rani, Fabrizio De Ponti, GC Alexander, GK Isbister, H Verdoux, J Nielsen, J Papay, K Jolly, K Titier, LC Wittkampf, LS Schneider, Miriam Sturkenboom, NP Tatonetti, P Kannankeril, P Manu, P Vigneault, RC Owens Jr, RR Shah, S Dhillon, S Hennessy, S Kongsamut, S Leucht, SM Straus, Ugo Moretti, W Crumb, W Crumb, WA Ray, WA Ray, WJ Crumb Jr, WP Stephenson, Y Suzuki   +53 more
core   +4 more sources

Recent advances: rheumatology [PDF]

, 2000
No abstract ...
Madhok, R., Kerr, H., Capell, H.A.
core   +4 more sources

Melanosis Secondary to Drugs: A Real‐World Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

Skin Research and Technology, Volume 31, Issue 12, December 2025.
ABSTRACT Background Melanosis is an acquired hyperpigmentation disorder that can be associated with the use of medications; timely identification and discontinuation of relevant medications is an important aspect of clinical management. Objective This study investigates the relationship between melanosis and drug exposure based on data from the FDA ...
Yilin Zhao, Hanzhang Xie, Zhanshuo Xiao, Yansong Zhao   +3 more
wiley   +1 more source

Kalkulierte parenterale Initialtherapie bakterieller Infektionen: Sicherheit und Verträglichkeit

GMS Infectious Diseases, 2020
This is the fourth chapter of the guideline “Calculated initial parenteral treatment of bacterial infections in adults – update 2018” in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V.
Stahlmann, Ralf, Lode, Hartmut
doaj   +1 more source

Special considerations for therapeutic choice of non-vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation. [PDF]

, 2017
Nonvalvular atrial fibrillation (AF) is a risk factor for stroke in elderly patients. Although warfarin has been used to prevent AF-associated stroke for more than 50 years, non-vitamin K antagonist oral anticoagulants (NOACs) including dabigatran ...
Alexander, Ansell, Bathala, Camm, Connolly, Connolly, Eriksson, Giugliano, Goto, Granger, Harder, Heidbuchel, Hori, Hori, JCS Joint Working Group, Kimura, Matsushima, Mega, Mendell, Ogata, Ogawa, Oldgren, Oldgren, Patel, Sardar, Savelieva, Shen, Tanahashi, Tanigawa, Wong   +29 more
core   +1 more source

Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance [PDF]

, 2020
Tomonori Ishii, Yoko Hirano, Noriko Matsumoto, Ami Takata, Yoshiki Sekijima, Mitsuharu Ueda, Yukio Ando   +6 more
openalex   +1 more source

Adverse drug reactions induced by cardiovascular drugs in outpatients

Pharmacy Practice, 2008
Considering increased use of cardiovascular drugs and limitations in pre-marketing trials for drug safety evaluation, post marketing evaluation of adverse drug reactions (ADRs) induced by this class of medicinal products seems necessary.Objectives: To ...
Gholami K, Ziaie S, Shalviri G
doaj  

Postmarketing surveillance is needed [PDF]

BMJ, 2004
EDITOR—The drug point by Harrison-Woolrych and Clark on nose bleeds associated with risperidone highlights a real need for effective communication in the medical fraternity.1 The problem with doctors is that they are quite enthusiastic in prescribing new drugs. …
openaire   +1 more source